Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci

Clin Infect Dis. 2003 Sep 15;37(6):794-9. doi: 10.1086/377540. Epub 2003 Aug 23.

Abstract

To determine the outcome of Staphylococcus aureus bacteremia (SAB) on mortality, including the impact of methicillin resistance and an initial delay (< or =48 h) of appropriate antibiotics, a retrospective cohort study including 238 patients with SAB was performed. By logistic regression, noneradicable or noneradicated foci, underlying cirrhosis, and cancer were found to be independent predictors of mortality. In patients with eradicable foci, there were no significant differences in the associated mortality rate between methicillin-resistant SAB (11%) and methicillin-susceptible SAB (13%), and between inappropriate (13%) and appropriate (10%) empirical therapy, respectively (P=.79 and P=.78, respectively). By logistic regression, it was found that, in the subgroup of patients with noneradicable foci, underlying cirrhosis (odds ratio [OR], 3.1) and methicillin-resistant SAB (OR, 2.4) were independently associated with mortality.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia / drug therapy
  • Bacteremia / microbiology
  • Bacteremia / mortality*
  • Cohort Studies
  • Cross Infection
  • Female
  • Humans
  • Male
  • Methicillin / pharmacology
  • Methicillin Resistance / physiology*
  • Middle Aged
  • Odds Ratio
  • Retrospective Studies
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / mortality*
  • Staphylococcus aureus* / drug effects
  • Survival Rate

Substances

  • Anti-Bacterial Agents
  • Methicillin